| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/16/2013 | WO2013043012A3 Novel use of leucyl trna synthetase |
| 05/16/2013 | WO2013040466A3 Methods and compositions for detecting the presence of one or more autoantibodies |
| 05/16/2013 | WO2013016425A9 Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease |
| 05/16/2013 | WO2013001369A3 Therapeutic and diagnostic target |
| 05/16/2013 | WO2012175454A3 In vitro assay method using immunological technique |
| 05/16/2013 | WO2012173994A3 Phase changing formulations of nucleic acid payloads |
| 05/16/2013 | WO2012167163A3 Methods and compositions for detecting endometrial or ovarian cancer |
| 05/16/2013 | WO2012135834A3 Dialysis like therapeutic (dlt) device |
| 05/16/2013 | WO2012135696A3 Methods and compositions for the diagnosis, classification, and treatment of cancer |
| 05/16/2013 | WO2011123601A3 Whole mouth malodor control by a combination of antibacterial and deodorizing agents |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130124099 Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby |
| 05/16/2013 | US20130123484 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 05/16/2013 | US20130123475 Non-Fluorescent Quencher Compounds and Biomolecular Assays |
| 05/16/2013 | US20130123328 Methods and compositions for treating cancer |
| 05/16/2013 | US20130123285 Compositions and Methods for Targeting A3G:RNA Complexes |
| 05/16/2013 | US20130123201 Modulation of cytokine-induced chronic inflammatory responses |
| 05/16/2013 | US20130123185 Methods of treating and diagnosing acute chest syndrome |
| 05/16/2013 | US20130123146 Method of making a microbead array with attached biomolecules |
| 05/16/2013 | US20130123145 Methods. particles, and assay kits for identifying presence of biological parameters |
| 05/16/2013 | US20130123140 Identification of compounds modifying a cellular response |
| 05/16/2013 | US20130123137 Method for the characterization of intermolecular interactions |
| 05/16/2013 | US20130123134 Small molecule printing |
| 05/16/2013 | US20130123133 Screening methods |
| 05/16/2013 | US20130123132 Method for Diagnosing Propionibacterium Bacterial Infections |
| 05/16/2013 | US20130123131 Process for Ensuring Consistency and Reproducibility of a Diagnostic or Research Method |
| 05/16/2013 | US20130123127 Microarrays and uses thereof |
| 05/16/2013 | US20130123122 Secreted proteins and uses thereof |
| 05/16/2013 | US20130122606 Method and device for chemical and/or biological analysis |
| 05/16/2013 | US20130122605 Methods for Ionophorically Screening Pore Forming Bacterial Protein Toxins and Receptors |
| 05/16/2013 | US20130122599 Fragmentation Reagents For Mass Spectrometry |
| 05/16/2013 | US20130122597 Simultaneous determination of multiple analytes in industrial water system |
| 05/16/2013 | US20130122595 Determining formation fluid composition |
| 05/16/2013 | US20130122532 Methods of Improving Auto-Coding Capabilities for Biosensors and Devices for Same |
| 05/16/2013 | US20130122530 Prediction and recognition of acute kidney injury after surgery |
| 05/16/2013 | US20130122529 HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA |
| 05/16/2013 | US20130122528 Compositions and methods for assessing appendicitis |
| 05/16/2013 | US20130122527 Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome |
| 05/16/2013 | US20130122523 In vitro process for the quick determaination of a patient's status relating to infection with mycobacterium tuberculosis |
| 05/16/2013 | US20130122522 Assessing mammals for vascular diseases and valvular diseases |
| 05/16/2013 | US20130122520 Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
| 05/16/2013 | US20130122519 Method for Detection of Ischemic Strokes |
| 05/16/2013 | US20130122518 Wellness panel |
| 05/16/2013 | US20130122515 Method for the selective determination of procalcitonin 1-116 |
| 05/16/2013 | US20130122512 Method for determination or evaluation of test substance |
| 05/16/2013 | US20130122509 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
| 05/16/2013 | US20130122492 Detection, isolation and analysis of rare cells in biological fluids |
| 05/16/2013 | US20130122488 Method of detecting sparse particles in a solution using a light-emitting probe |
| 05/16/2013 | US20130122047 Streptococcus pyogenes antigens |
| 05/16/2013 | US20130122030 S. epidermidis antigens |
| 05/16/2013 | US20130122027 Neoepitope detection of disease using protein arrays |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121999 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 05/16/2013 | US20130121998 Diagnosis of Myocardial Autoimmunity in Heart Disease |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | US20130121914 Treatment drug for autoimmune diseases and allergic diseases |
| 05/16/2013 | US20130121883 Chemical analyzer |
| 05/16/2013 | US20130121879 Magnetic-Field Measurement Device |
| 05/16/2013 | US20130121875 Holding device |
| 05/16/2013 | US20130118274 Water analysis sensor cartridge with transport container |
| 05/16/2013 | US20130118239 Remote Water Quality Monitoring |
| 05/16/2013 | US20130118238 Test solvent for evaluating the compatibility of biologically active substances and graft copolymers |
| 05/16/2013 | US20130118236 Aquatic pollution monitoring |
| 05/16/2013 | US20130118234 Apparatus for measuring air amount of engine oil and method using the same |
| 05/16/2013 | US20130118228 Stress-based sensor, method, and applications |
| 05/16/2013 | DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus |
| 05/16/2013 | DE102011118600A1 Verfahren und Vorrichtung zur gerichteten Immobilisierung von Nano- und Mikroobjekten auf einer Substratoberfläche, damit erhaltene Immobilisate und deren Verwendung Method and apparatus for directed immobilization of nano- and micro-objects on a substrate surface, thus resulting immobilizates and their use |
| 05/16/2013 | DE102011118386A1 Verfahren zur Isolierung von Zellen und Biopartikeln A method for isolating cells and bioparticles |
| 05/16/2013 | DE102011118107A1 Liquid mixture for testing and validating test device for inspecting persons or substance, consists of mixture of glycerol, ethanoic acid and water |
| 05/16/2013 | DE102011118095A1 Liquid mixture for testing and validating test devices for inspecting objects or persons, includes glycerol, where glycerol portion is ninety percent by weight |
| 05/16/2013 | DE102011118094A1 Liquid mixture for testing and validating test devices for inspecting articles or persons, has proportions of glycerol, ethanol and water of approximately specific grams equivalent weight percentage, respectively |
| 05/16/2013 | DE102009057541B4 Vorrichtung zum Wiegen von Behältern Device for weighing containers |
| 05/16/2013 | DE102009010667B4 Vorrichtung zum Verbringen und Trennen von Zellmaterial aus einer flüssigen Probe auf einen Objektträger Device for bringing and separating cellular material from a liquid sample on a slide |
| 05/16/2013 | CA2856200A1 Antibody specific for trans-resveratrol and use thereof |
| 05/16/2013 | CA2856167A1 Biomarkers for bladder cancer and methods using the same |
| 05/16/2013 | CA2855363A1 Paper based diagnostic test |
| 05/16/2013 | CA2855356A1 Biomarkers of response to proteasome inhibitors |
| 05/16/2013 | CA2855121A1 System and method for color preparation and management |
| 05/16/2013 | CA2854832A1 Methods and systems for identification of causal genomic variants |
| 05/16/2013 | CA2854806A1 Multispecific and multivalent binding proteins and uses thereof |
| 05/16/2013 | CA2854805A1 Method of predicting breast cancer prognosis |
| 05/16/2013 | CA2854665A1 Gene expression signatures of neoplasm responsiveness to theraphy |
| 05/16/2013 | CA2854587A1 A method for determining the propensity for calcification |
| 05/16/2013 | CA2854422A1 Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
| 05/16/2013 | CA2854372A1 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
| 05/16/2013 | CA2854333A1 Biomarkers for sanfilippo syndrome and uses thereof |
| 05/16/2013 | CA2853862A1 New method for evaluation of target in histological sample |
| 05/16/2013 | CA2853328A1 Prognostic method for checking efficacy of micro rna-122 inhibitors in hcv+ patients |
| 05/16/2013 | CA2853220A1 Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
| 05/16/2013 | CA2850449A1 Dynamic of sflt-1 or endoglin/pigf ratio as an indicator for imminent preeclampsia and/or hellp syndrome |
| 05/16/2013 | CA2795574A1 Preliminary diagnostic system |
| 05/15/2013 | EP2592423A1 Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
| 05/15/2013 | EP2592422A1 Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
| 05/15/2013 | EP2592421A1 Diagnosis of sepsis and systemic inflammatory response syndrome |
| 05/15/2013 | EP2592420A1 Method and use of metabolic compounds for diagnosing stroke |
| 05/15/2013 | EP2592419A1 Method for detection of infection with human cytomegalovirus |
| 05/15/2013 | EP2592418A1 Diagnostic detecting device |
| 05/15/2013 | EP2592417A2 Biological measuring device with auto coding capabilities, a test strip with a code pattern and method of reading a code pattern associated with a test strip adapted for use with a biological measuring device |
| 05/15/2013 | EP2592416A2 Device for supplying simulated gas |
| 05/15/2013 | EP2592415A2 Exhaust gas analysis system and program for this system |